stockrowChemed Corporation
CHE Healthcare Medical Care Facilities
Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- +23.1%
- Free cash flow
- −45.3%
Quarter to September 2026, against a year earlier
Follow CHE
Alert me
Chemed Corporation (CHE) Return on invested capital
Chemed Corporation's return on invested capital over the twelve months to 30 September 2026 was 22.1%, down 1.3 percentage points from fiscal 2025 (23.4%). Over the past ten years it has ranged from 11.2% (fiscal 2017) to 27.9% (fiscal 2020); the current reading is higher than 55% of that period. That is above the Medical Care Facilities industry median of 5.47% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 23.4% | (0.99) |
| FY2024 | 24.4% | (0.87) |
| FY2023 | 25.2% | (0.89) |
| FY2022 | 26.1% | 0.13 |
| FY2021 | 26.0% | (1.90) |
| FY2020 | 27.9% | 9.16 |
| FY2019 | 18.7% | (3.36) |
| FY2018 | 22.1% | 10.87 |
| FY2017 | 11.2% | (6.88) |
| FY2016 | 18.1% | (1.46) |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| CHE Chemed Corporation | 22.1% |
| PACS PACS Group, Inc. compare | 19.3% |
| DVA DaVita Inc. compare | 13.5% |
| ENSG The Ensign Group, Inc. compare | 13.4% |
| CON Concentra Group Holdings Parent, Inc. compare | 12.7% |
| OPCH Option Care Health, Inc. compare | 9.72% |
| UHS Universal Health Services, Inc. compare | 9.42% |
| FMS Fresenius Medical Care AG & Co. KGaA compare | 5.47% |
| LFST LifeStance Health Group, Inc. compare | 4.25% |
| Medical Care Facilities industry median | 5.47% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on CHE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement